Home › Companies › VERRICA PHARMACEUTICALS INC. › 2023-2024
At VERRICA PHARMACEUTICALS INC.'s shareholder meeting held June 6, 2024, in the 2023-2024 proxy season, 87 asset managers reported how they voted in their SEC Form N-PX filings, covering 593 separate fund positions. Their filings are grouped here into 5 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS… — FOR was 87% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: VERRICA PHARMACEUTICALS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 10, 2024.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and VERRICA PHARMACEUTICALS INC.’s Form 8-K, filed June 10, 2024 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of June 6, 2024: 4 items on VERRICA PHARMACEUTICALS INC.’s Form 8-K, filed June 10, 2024: 2 elected · 2 without a stated outcome.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2023-2024
Explore VERRICA PHARMACEUTICALS INC. in the interactive database Compare manager voting policies
These tallies are VERRICA PHARMACEUTICALS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 10, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Ted White | 13,091,028 | -- | -- | 1,882,703 | -- | 87% | Elected | — |
| Elect Director: Mark Prygocki | 12,503,147 | -- | -- | 2,470,584 | -- | 84% | Elected | — |
| 2. Approval, on an advisory basis, of the compensation paid to the Company's named executive officers, as disclosed in the Proxy Statement | 12,760,245 | 1,932,076 | 281,410 | -- | -- | 87% | Not verified | — |
| 4. Ratification of the appointment of KPMG LLP as independent registered public accounting firm for the fiscal year ending December 31, 2024 | 37,151,871 | 678,830 | 9,132 | -- | -- | 98% | Not verified | — |
Source: VERRICA PHARMACEUTICALS INC., Form 8-K, filed with the SEC on June 10, 2024 — read the filing on EDGAR.
Each item below shows how the 87 asset managers that disclosed a VERRICA PHARMACEUTICALS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of VERRICA PHARMACEUTICALS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 2 wordings of this item as funds reported it.
84% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Mark Prygocki
VERRICA PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Mark Prygocki”): 12,503,147 for, 2,470,584 withheld, per its Form 8-K filed June 10, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “All nominees were elected.”
Support: 84% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 32 asset managers below reported 212,723 for, 331,448 withheld, 5,867 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 0 | 0 | 0 | 161,893 | Withhold |
| Vanguard | 89,515 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 74,251 | 0 | 0 | 0 | For |
| Fidelity | 48,944 | 0 | 0 | 0 | For |
| Global X | 0 | 0 | 0 | 47,963 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 31,361 | Withhold |
| Lincoln Financial | 0 | 0 | 0 | 17,600 | Withhold |
| Northern Trust | 0 | 0 | 0 | 15,551 | Withhold |
| TIAA | 0 | 0 | 0 | 14,462 | Withhold |
| Equitable | 0 | 0 | 0 | 9,040 | Withhold |
| Pacific Life | 0 | 0 | 0 | 6,467 | Withhold |
| Charles Schwab | 0 | 0 | 0 | 4,616 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 3,701 | Withhold |
| Bridge Builder Trust | 0 | 0 | 3,653 | 0 | Abstain |
| ProShares | 0 | 0 | 0 | 3,405 | Withhold |
| Principal | 0 | 0 | 0 | 2,443 | Withhold |
| DWS | 0 | 0 | 0 | 2,308 | Withhold |
| John Hancock | 0 | 0 | 2,214 | 0 | Abstain |
| Goldman Sachs | 0 | 0 | 0 | 1,953 | Withhold |
| American Century | 0 | 0 | 0 | 1,725 | Withhold |
| Calvert | 0 | 0 | 0 | 1,724 | Withhold |
| Voya | 0 | 0 | 0 | 1,641 | Withhold |
| State Street | 0 | 0 | 0 | 1,367 | Withhold |
| PENN SERIES FUNDS INC | 0 | 0 | 0 | 900 | Withhold |
| Nationwide | 0 | 0 | 0 | 612 | Withhold |
Showing the 25 largest of 32 asset managers. All 32 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
87% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Ted White
VERRICA PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Ted White”): 13,091,028 for, 1,882,703 withheld, per its Form 8-K filed June 10, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “All nominees were elected.”
Support: 87% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 32 asset managers below reported 550,030 for, 8 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 161,893 | 0 | 0 | 0 | For |
| Vanguard | 89,515 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 74,251 | 0 | 0 | 0 | For |
| Fidelity | 48,944 | 0 | 0 | 0 | For |
| Global X | 47,963 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 31,361 | 0 | 0 | 0 | For |
| Lincoln Financial | 17,600 | 0 | 0 | 0 | For |
| Northern Trust | 15,551 | 0 | 0 | 0 | For |
| TIAA | 14,462 | 0 | 0 | 0 | For |
| Equitable | 9,040 | 0 | 0 | 0 | For |
| Pacific Life | 6,467 | 0 | 0 | 0 | For |
| Charles Schwab | 4,616 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 3,701 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 3,653 | 0 | 0 | 0 | For |
| ProShares | 3,405 | 0 | 0 | 0 | For |
| Principal | 2,443 | 0 | 0 | 0 | For |
| DWS | 2,308 | 0 | 0 | 0 | For |
| John Hancock | 2,214 | 0 | 0 | 0 | For |
| Goldman Sachs | 1,953 | 0 | 0 | 0 | For |
| American Century | 1,725 | 0 | 0 | 0 | For |
| Calvert | 1,724 | 0 | 0 | 0 | For |
| Voya | 1,641 | 0 | 0 | 0 | For |
| State Street | 1,367 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 900 | 0 | 0 | 0 | For |
| Nationwide | 612 | 0 | 0 | 0 | For |
Showing the 25 largest of 32 asset managers. All 32 are in the interactive database (link above).
Combines 8 wordings of this item as funds reported it.
87% Majority: yes · of votes cast
Description as filed by funds: APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY STATEMENT.
VERRICA PHARMACEUTICALS INC.’s own tally for this item (“2. Approval, on an advisory basis, of the compensation paid to the Company's named executive officers, as disclosed in the Proxy Statement”): 12,760,245 for, 1,932,076 against, per its Form 8-K filed June 10, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 87% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 161,893 | 0 | 0 | 0 | For |
| Vanguard | 89,515 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 74,251 | 0 | 0 | 0 | For |
| Fidelity | 48,944 | 0 | 0 | 0 | For |
| Global X | 47,963 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 31,361 | 0 | 0 | 0 | For |
| Lincoln Financial | 17,600 | 0 | 0 | 0 | For |
| Northern Trust | 15,551 | 0 | 0 | 0 | For |
| TIAA | 14,462 | 0 | 0 | 0 | For |
| Equitable | 9,040 | 0 | 0 | 0 | For |
| Pacific Life | 6,467 | 0 | 0 | 0 | For |
| Charles Schwab | 4,616 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 3,701 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 3,653 | 0 | 0 | 0 | For |
| ProShares | 3,405 | 0 | 0 | 0 | For |
| Principal | 2,443 | 0 | 0 | 0 | For |
| DWS | 2,308 | 0 | 0 | 0 | For |
| John Hancock | 2,214 | 0 | 0 | 0 | For |
| Goldman Sachs | 1,953 | 0 | 0 | 0 | For |
| American Century | 0 | 1,725 | 0 | 0 | Against |
| Calvert | 0 | 1,724 | 0 | 0 | Against |
| Voya | 1,641 | 0 | 0 | 0 | For |
| State Street | 1,367 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 900 | 0 | 0 | 0 | For |
| Nationwide | 612 | 0 | 0 | 0 | For |
Fund voting reports, all 32 managers: 546,345 for, 3,693 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 5,584,505 | 0 | 0 | 0 | For |
| Avoro Capital Advisors LLC | 3,101,950 | 0 | 0 | 0 | For |
| State Street | 322,517 | 182 | 0 | 0 | For |
| BlackRock | 117,742 | 53 | 0 | 0 | For |
| Northern Trust | 101,837 | 0 | 0 | 0 | For |
| Wellington | 91,822 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 49,281 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 31,034 | 0 | 0 | 0 | For |
| STIFEL NICOLAUS & CO INC \MO\ | 27,250 | 0 | 0 | 0 | For |
| J. Goldman & Co LP | 15,525 | 0 | 0 | 0 | For |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 14,704 | 0 | 0 | 0 | For |
| Nuveen | 14,462 | 0 | 0 | 0 | For |
| Rhumbline | 6,725 | 393 | 0 | 0 | Mixed |
| Two Sigma | 13,830 | 0 | 0 | 0 | For |
| TRUIST FINANCIAL CORP | 10,545 | 0 | 0 | 0 | For |
| NEW YORK STATE COMMON RETIREMENT FUND | 9,769 | 0 | 0 | 0 | For |
| STONERIDGE INVESTMENT PARTNERS LLC | 9,767 | 0 | 0 | 0 | For |
| Invesco | 0 | 8,470 | 0 | 0 | Against |
| JPMorgan | 8,185 | 0 | 0 | 0 | For |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0 | 7,444 | 0 | 0 | Against |
| Vanguard | 7,157 | 0 | 0 | 0 | For |
| Goldman Sachs | 6,800 | 0 | 0 | 0 | For |
| BALYASNY ASSET MANAGEMENT L.P. | 5,828 | 0 | 0 | 0 | For |
| BANK OF AMERICA NA | 5,584 | 0 | 0 | 0 | For |
| Dimensional | 4,731 | 0 | 0 | 0 | For |
Institutional-manager reports, all 70 managers: 9,604,184 for, 28,384 against, 7,118 1 year. Showing the 25 largest; every one is in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
94% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: INDICATION, ON AN ADVISORY BASIS, OF THE FREQUENCY OF FUTURE ADVISORY VOTES ON THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 0 | 0 | 0 | 0 | -- |
| Vanguard | 0 | 0 | 0 | 0 | -- |
| BUFFALO FUNDS | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| Global X | 0 | 0 | 0 | 0 | -- |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 0 | -- |
| Lincoln Financial | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| TIAA | 0 | 0 | 0 | 0 | -- |
| Equitable | 0 | 0 | 0 | 0 | -- |
| Pacific Life | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| AIG/SunAmerica | 0 | 0 | 0 | 0 | -- |
| Bridge Builder Trust | 0 | 0 | 0 | 0 | -- |
| ProShares | 0 | 0 | 0 | 0 | -- |
| Principal | 0 | 0 | 0 | 0 | -- |
| DWS | 0 | 0 | 0 | 0 | -- |
| John Hancock | 0 | 0 | 0 | 0 | -- |
| Goldman Sachs | 0 | 0 | 0 | 0 | -- |
| American Century | 0 | 0 | 0 | 0 | -- |
| Calvert | 0 | 0 | 0 | 0 | -- |
| Voya | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| PENN SERIES FUNDS INC | 0 | 0 | 0 | 0 | -- |
| Nationwide | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 32 managers: 550,030 1 year, 8 3 year. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 0 | 0 | 0 | 0 | -- |
| Avoro Capital Advisors LLC | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| Wellington | 0 | 0 | 0 | 0 | -- |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| MELLON INVESTMENTS Corp | 0 | 0 | 0 | 0 | -- |
| STIFEL NICOLAUS & CO INC \MO\ | 0 | 0 | 0 | 0 | -- |
| J. Goldman & Co LP | 0 | 0 | 0 | 0 | -- |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 0 | 0 | 0 | 0 | -- |
| Nuveen | 0 | 0 | 0 | 0 | -- |
| Rhumbline | 6,725 | 393 | 0 | 0 | Mixed |
| Two Sigma | 0 | 0 | 0 | 0 | -- |
| TRUIST FINANCIAL CORP | 0 | 0 | 0 | 0 | -- |
| NEW YORK STATE COMMON RETIREMENT FUND | 0 | 0 | 0 | 0 | -- |
| STONERIDGE INVESTMENT PARTNERS LLC | 0 | 0 | 0 | 0 | -- |
| Invesco | 0 | 0 | 0 | 0 | -- |
| JPMorgan | 0 | 0 | 0 | 0 | -- |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| Vanguard | 0 | 0 | 0 | 0 | -- |
| Goldman Sachs | 0 | 0 | 0 | 0 | -- |
| BALYASNY ASSET MANAGEMENT L.P. | 0 | 0 | 0 | 0 | -- |
| BANK OF AMERICA NA | 0 | 0 | 0 | 0 | -- |
| Dimensional | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 68 managers: 6,725 for, 393 against, 9,627,287 1 year, 4,731 3 year. Showing the 25 largest; every one is in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Ratification of the selection by the Audit Committee of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024.
VERRICA PHARMACEUTICALS INC.’s own tally for this item (“4. Ratification of the appointment of KPMG LLP as independent registered public accounting firm for the fiscal year ending December 31, 2024”): 37,151,871 for, 678,830 against, per its Form 8-K filed June 10, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 33 asset managers below reported 550,538 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 161,893 | 0 | 0 | 0 | For |
| Vanguard | 89,515 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 74,251 | 0 | 0 | 0 | For |
| Fidelity | 48,944 | 0 | 0 | 0 | For |
| Global X | 47,963 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 31,361 | 0 | 0 | 0 | For |
| Lincoln Financial | 17,600 | 0 | 0 | 0 | For |
| Northern Trust | 15,551 | 0 | 0 | 0 | For |
| TIAA | 14,462 | 0 | 0 | 0 | For |
| Equitable | 9,040 | 0 | 0 | 0 | For |
| Pacific Life | 6,467 | 0 | 0 | 0 | For |
| Charles Schwab | 4,616 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 3,701 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 3,653 | 0 | 0 | 0 | For |
| ProShares | 3,405 | 0 | 0 | 0 | For |
| Principal | 2,443 | 0 | 0 | 0 | For |
| DWS | 2,308 | 0 | 0 | 0 | For |
| John Hancock | 2,214 | 0 | 0 | 0 | For |
| Goldman Sachs | 1,953 | 0 | 0 | 0 | For |
| American Century | 1,725 | 0 | 0 | 0 | For |
| Calvert | 1,724 | 0 | 0 | 0 | For |
| Voya | 1,641 | 0 | 0 | 0 | For |
| State Street | 1,367 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 900 | 0 | 0 | 0 | For |
| Nationwide | 612 | 0 | 0 | 0 | For |
Showing the 25 largest of 33 asset managers. All 33 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 42,420,053 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 0.38% |
| 2 | Vanguard | 0.21% |
| 3 | BUFFALO FUNDS | 0.18% |
| 4 | Fidelity | 0.12% |
| 5 | Global X | 0.11% |
| 6 | QUANTITATIVE MASTER SERIES LLC | 0.07% |
| 7 | Lincoln Financial | 0.04% |
| 8 | Northern Trust | 0.04% |
| 9 | TIAA | 0.03% |
| 10 | Equitable | 0.02% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | PERCEPTIVE ADVISORS LLC | 13.16% |
| 2 | Avoro Capital Advisors LLC | 7.31% |
| 3 | State Street | 0.76% |
| 4 | BlackRock | 0.28% |
| 5 | Northern Trust | 0.24% |
| 6 | Wellington | 0.22% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 0.12% |
| 8 | MELLON INVESTMENTS Corp | 0.07% |
| 9 | STIFEL NICOLAUS & CO INC \MO\ | 0.06% |
| 10 | J. Goldman & Co LP | 0.04% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Paul B. Manning | — | 13D |
| Caligan Partners LP | — | 13G |
| Entities affiliated with Paul B. Manning | — | DEF14A |
| Armistice Capital, LLC | — | 13G |
| Perceptive Life Sciences Master Fund | — | DEF14A |
| Avoro Capital Advisors LLC. | — | DEF14A |
| Perceptive Advisors LLC | — | 13G |
| Ted White | — | DEF14A |
| Sean Stalfort | — | DEF14A |
| Geode Capital | — | 13F |
Percentages above are of 42,420,053 shares outstanding, as reported by VERRICA PHARMACEUTICALS INC. on its Form 10-Q dated May 7, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from VERRICA PHARMACEUTICALS INC.’s 10-Q dated May 7, 2024. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
VERRICA PHARMACEUTICALS INC. proxy season coverage: 2023-2024 (this page).
proxyvotesnow.com, “VERRICA PHARMACEUTICALS (VRCA) 2024 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/verrica-pharmaceuticals-inc/2024 (version of November 8, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.